We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Endotracheal Tube for Ventilator Patients

By HospiMedica staff writers
Posted on 29 Nov 2005
An improved endotracheal tube (ETT) for patients placed on ventilators for intermediate and extended-duration life support can remove secretions that might cause ventilator-associated pneumonia (VAP), the leading cause of death among hospital-acquired infections.

The CorEvacT ETT utilizes a balloon and suction catheter to remove infectious secretions at the seal. More...
The unit's innovative design removes the secretions regardless of patient position and utilizes an engineered coughing-seal countermeasure when the patient coughs. The ETT was developed by Christopher Grey, RN, a trauma intensive care unit nurse in the Ryder Trauma Center at the University of Miami (FL, USA), with assistance from a Space Alliance Technology Outreach Program (SATOP).

A big flaw of current ETTs is that they allow saliva and bacteria from the mouth and throat to collect on top of a balloon seal. When a patient moves or coughs, the infectious fluid seeps past the seal and into the lungs, producing VAP.

Design changes reduced the complexity of the new breathing tube while increasing clinical utility. The design has now been finalized so that a functional prototype can be built and testing can begin. "My objective with the CorEvac is to revolutionize the methodology of medicine from expensive treatment to inexpensive prevention, saving millions of dollars and, more importantly, people's lives,” said Nurse Grey. "In order to market the design, it must be as easy to use and manufacture as possible.”





Related Links:
U. of Miami

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Open Stapler
PROXIMATE Linear Cutter
Emergency Ventilator
Shangrila935
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.